Next 10 |
Merger activity increased last week with four new deals announced. The acquisition of HD Supply Holdings by The Home Depot. The acquisition of Foundation Building Materials by American Securities. For further details see: Merger Arbitrage Mondays - Home Depot B...
Virtusa receives shareholder approval. Virtusa still has outstanding regulatory hurdles to clear. Merger arbitrage cash spreads generate positive returns for the 8th straight week. For further details see: Merger Arbitrage Analysis And Spread Performance - November 22, 2...
Bristol Myers Squibb (BMY) has successfully completed its acquisition of MyoKardia (MYOK) in an all cash transaction for ~$13.1B.With the completion of the acquisition, MyoKardia shares have ceased trading on Nasdaq and the company now a wholly-owned subsidiary of Bristol Myers. Through the t...
EXPLORER -HCM Cardiac Imaging Data Presented at AHA 2020 Scientific Session with Simultaneous Publication in Circulation Mavacamten T reatment Resulted in Favorable Effect on Cardiac Structure -- Significantly Reduced Hypertrophy in Patien...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week aheadInvestors are likely to continue to hedge their bets between growth vs. value and vaccine plays vs. COVID shutdowns in th...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...
ECHO Data from EXPLORER-HCM Show Mavacamten Treatment Improved Cardiac Structure and Mitral Valve Function in Obstructive Hypertrophic Cardiomyopathy Patients Markers of Physical Activity from MAVERICK-HCM Accelerometry Data Correlated with ...
MyoKardia (MYOK) and the American College of Cardiology ((ACC)) have established a nationwide registry of hypertrophic cardiomyopathy ((HCM)), which leverages the ACC’s PINNACLE Cardiovascular Registry operated by Veradigm, an Allscripts (MDRX), business unit.The registry will support ...
BRISBANE, Calif. and WASHINGTON, Nov. 11, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (NASDAQ: MYOK), and the American College of Cardiology (ACC) announced the establishment of a nationwide registry of hypertrophic cardiomyopathy (HCM), which leverages the ACC’s PINNACLE Cardiovas...
Merger activity remained steady last week with four new deals announced. The acquisition of Endurance International Group Holdings by Clearlake Capital Group. The acquisition of Navistar International Corporation by TRATON SE. For further details see: Merger Ar...
News, Short Squeeze, Breakout and More Instantly...
EXPLORER -HCM Cardiac Imaging Data Presented at AHA 2020 Scientific Session with Simultaneous Publication in Circulation Mavacamten T reatment Resulted in Favorable Effect on Cardiac Structure -- Significantly Reduced Hypertrophy in Patien...
ECHO Data from EXPLORER-HCM Show Mavacamten Treatment Improved Cardiac Structure and Mitral Valve Function in Obstructive Hypertrophic Cardiomyopathy Patients Markers of Physical Activity from MAVERICK-HCM Accelerometry Data Correlated with ...
BRISBANE, Calif. and WASHINGTON, Nov. 11, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (NASDAQ: MYOK), and the American College of Cardiology (ACC) announced the establishment of a nationwide registry of hypertrophic cardiomyopathy (HCM), which leverages the ACC’s PINNACLE Cardiovas...